Diverse mechanisms and consequences of immunoadoption of neuromediator systems

Annals of the New York Academy of Sciences

Volumn 1144, Issue , 2008, Pages 56-60

  Goetzl, Edward J ^a   Chan, Robert C ^a   Yadav, Mahesh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

And vasoactive intestinal peptide (VIP); Corticotropin releasing hormone (CRH); Cytokines; Immunity; Inflammation; Macrophages; T cells

Indexed keywords

CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

CD4+ T LYMPHOCYTE; CONFERENCE PAPER; EFFECTOR CELL; HUMAN; HUMAN CELL; HYPOTHALAMUS; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MEMORY T LYMPHOCYTE; NEUROMODULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 56649109885     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1418.008     Document Type: Conference Paper

References (31)

1. Bellinger, D.L. et al. 1990. Neuropeptide innervation of lymphoid organs. Ann. N.Y. Acad. Sci. 594 : 17 33.
2. Goetzl, E.J., D.C. Adelman & S.P. Sreedharan. 1990. Neuroimmunology. Adv. Immunol. 48 : 161 190.
3. Felten, D.L. 1991. Neurotransmitter signaling of cells of the immune system: important progress, major gaps. Brain Behav. Immun. 5 : 2 8.
4. McCann, S.M. et al. 1998. Neuroimmunomodulation: molecular aspects, integrative systems, and clinical advances. Ann. N.Y. Acad. Sci. 840 : 1 866.
5. Chrousos, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332 : 1351 1362.
6. Elenkov, I.J. et al. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 108 : 374 381.
7. Irwin, M. 1994. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 4 : 29 47.
8. Karalis, K. et al. 1991. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254 : 421 423.
9. Mastorakos, G. et al. 1995. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology 136 : 4650 4658.
10. Kawahito, Y. et al. 1995. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37 : 544 551.
11. Webster, E.L. & E.B. De Souza. 1988. Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides. Endocrinology 122 : 609 617.
12. Audhya, T., R. Jain & C.S. Hollander. 1991. Receptor-mediated immunomodulation by corticotropin-releasing factor. Cell Immunol. 134 : 77 84.
13. Singh, V.K. 1989. Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J. Neuroimmunol. 23 : 257 262.
14. Singh, V.K. & S.J. Leu. 1990. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci. Lett. 120 : 151 154.
15. Angioni, S. et al. 1993. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci. 53 : 1735 1742.
16. Koshida, H. & Y. Kotake. 1994. Corticotropin-releasing hormone enhances the superoxide anion production of rabbit peritoneal macrophages stimulated with N-formyl-methionyl-leucyl-phenylalanine. Life Sci. 54 : 539 543.
17. Goetzl, E.J. et al. 1998. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann. N.Y. Acad. Sci. 840 : 540 550.
18. Delgado, M. & D. Ganea. 2001. Cutting edge: Is vasoactive intestinal peptide a type 2 cytokine? J. Immunol. 166 : 2907 2912.
19. Voice, J.K. et al. 2002. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul. Pept. 109 : 199 208.
20. Xia, M. et al. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156 : 160 167.
21. Sun, L. & D. Ganea. 1993. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J. Neuroimmunol. 48 : 59 69.
22. Delgado, M. et al. 1999. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J. Neuroimmunol. 96 : 167 181.
23. Delgado, M. et al. 2000. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression. Ann. N.Y. Acad. Sci. 921 : 68 78.
24. Voice, J.K. et al. 2001. Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J. 15 : 2489 2496.
25. Goetzl, E.J. et al. 2001. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc. Natl. Acad. Sci. USA 98 : 13854 13859.
26. Martinez, C. et al. 1999. Regulation of VIP production and secretion by murine lymphocytes. J. Neuroimmunol. 93 : 126 138.
27. Delgado, M., J. Leceta & D. Ganea. 2002. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells. FASEB J. 16 : 1844 1846.
28. Yadav, M., J. Rosenbaum & E.J. Goetzl. 2008. Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile. J. Immunol. 180 : 2772 2776.
29. Mangan, P.R. et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 : 231 234.
30. Weaver, C.T. et al. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 : 677 688.
31. Korn, T. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 : 484 487.